Bookmark and Share
azobenzene (CID 2272) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(9)
 
 
Inactive(539)
 
 
Inconclusive(100)
 
 
Unspecified(22)
 
 
Top Targets:
NR LBD PPAR(26)
 
 
 
NR LBD ER(18)
 
 
 
 
NR LBD AR(18)
 
 
NR LBD TR(16)
 
 
 
NR LBD VDR(13)
 
 
 
BioAssay Types:
Confirmatory(373)
 
 
 
 
Summary(48)
 
 
 
Literature(12)
 
 
 
Screening(4)
 
 
BioActivity Types:
Potency(370)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 332    Data Row: 670   Total Pages: 34   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID17390028]
Potency 31.6228Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
2
[SID144208656]
Potency-Replicate_1 49.4975qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line [AID743079, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
3
[SID48413252]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
4
[SID48413252]
DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other]
View
5
[SID48413252]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other]
View
6
[SID48413252]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
7
[SID17390028]
Cell Viability - Jurkat [AID426, Type: confirmatory]
View
8
[SID17390028]
Cellular Toxicity (caspase-3) Jurkat [AID655, Type: confirmatory]
View
9
[SID17390028]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_7, Type: other]
View
10
[SID8149758]
Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other]
View
11
[SID8149758]
Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other]
View
12
[SID8149758]
Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other]
View
13
[SID8149758]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other]
View
14
[SID17390028]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813, Type: other]
View
15
[SID17390028]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
16
[SID26753122]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
17
[SID8149758]
Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other]
View
18
[SID8149758]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other]
View
19
[SID8149758]
Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other]
View
20
[SID103247002]
Partition coefficient (logP) [AID23714, Type: Literature]
View